# Resurrect Bio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/resurrect-bio

- Industry: Agribusiness
- Headquarters: London, UK
- Website: www.resurrect.bio/
- Total disclosed funding: $20M
- Latest round: Series A (May 13, 2026)
- Investors on record: 7

## About

Based in London, UK, and founded in 2021 by its CEO, Dr. Cian Duggan, and co-founder, Dr. Tolga Bozkurt, Resurrect Bio Ltd. operates as a plant biotech company that works to improve crop species' immune systems to prevent the spread of illnesses induced by climate change. In May 2026, Resurrect Bio Ltd raised USD 10.3 million in series A funding led by returning investor Corteva Catalyst, with participation from other returning investors Pymwymic, Calculus Capital, Future Planet Capital, SynBioVen, and AgFunder.

Resurrect Bio Ltd. creates a crop immune system that allows soy crops to protect themselves against diseases such as soybean cyst nematode, which causes significant production loss. It also permits the reviving of important immune resistance genes (R-genes) that have been lost during generations of breeding by utilizing its technology of immune receptor networks in plants and pathogen-effector biology. 

Resurrect Bio primarily generates revenue through partnerships and collaborations with seed companies and agricultural firms, where it provides disease-resistance trait discovery using its FloraFold® AI platform and gene-editing insights. Instead of directly commercializing seeds, the company supplies validated targets and technologies that partners integrate into their breeding pipelines, enabling licensing, milestone payments, and potential downstream royalty streams as improved crop varieties reach market.


Resurrect Bio will use the funding to scale its team, advance its AI-driven gene discovery platform, and accelerate development of disease-resistance traits for major crops. The investment supports commercial partnerships with seed companies and enables deployment of sustainable crop protection solutions.

## Funding rounds

- Series A, May 13, 2026, $10M — Calculus Capital, AgFunder, Future Planet Capital, Pymwymic, SynBioVen, Corteva Catalyst
- Series A, Feb 17, 2026, $8.1M — Calculus Capital, AgFunder, Future Planet Capital, Pymwymic, SynBioVen, Corteva Catalyst
- Seed, Mar 22, 2023, $1.9M — AgFunder, SynBioVen, Shake Climate Change

## Investors

- AgFunder (https://capitalatlas.ai/funds/agfunder) — Seed, Series A
- SynBioVen (https://capitalatlas.ai/funds/synbioven) — Seed, Series A
- Shake Climate Change (https://capitalatlas.ai/funds/shake-climate-change) — Seed
- Calculus Capital (https://capitalatlas.ai/funds/calculus-capital) — Series A
- Future Planet Capital (https://capitalatlas.ai/funds/future-planet-capital) — Series A
- Pymwymic (https://capitalatlas.ai/funds/pymwymic) — Series A
- Corteva Catalyst (https://capitalatlas.ai/funds/corteva-catalyst) — Series A